Focus

The South Park jinx could be coming for high-flying weight-loss stocks

Posted on:

If historical patterns hold true, the recent Ozempic storyline on South Park could potentially signal a temporary peak in the stock prices of obesity drug manufacturers. It has been observed that companies prominently featured in the animated comedy often experience a decline in their stock performance the following year. According to Spectra Markets, the median stock underperforms the S&P 500 by 7% one year after appearing on South Park.

Focus

Salesforce Stock Sinks on Revenue Miss, Weak Outlook

Posted on:

Salesforce, a customer relationship management (CRM) company, experienced a drop in its share value by over 17% during extended trading on Wednesday. This decline followed the release of its fiscal first-quarter earnings report, which revealed revenue figures that fell short of analysts’ estimates and provided guidance for the second quarter that was weaker than expected.